Brief: Julian Singer Says JDS1 LLC Filed Complaint Against Catalyst Biosciences In Delaware Court Of Chancery
April 21 (Reuters) - Catalyst Biosciences Inc CBIO.O :
* JULIAN SINGER SAYS ON APRIL 20, JDS1 LLC FILED COMPLAINT
AGAINST
CATALYST BIOSCIENCES IN THE DELAWARE COURT OF CHANCERY - SEC
FILING
* JULIAN SINGER SAYS JDS1 LLC FILED COMPLAINT AGAINST
CATALYST
BIOSCIENCES SEEKING TO COMPEL TO PRODUCE DOCUMENTS RESPONSIVE
TO INSPECTION DEMAND
* JULIAN SINGER - JDS1 LLC CONTINUES TO TAKE NECESSARY STEPS
TO
PREPARE FOR PROXY CONTEST IN CONNECTION WITH CATALYST
BIOSCIENCES' 2022 ANNUAL MEETING
Further company coverage: CBIO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Gyre Therapeutics
See all newsBrief: Gyre Therapeutics - Enters Employment Agreement With Ying Luo As CEO - SEC Filing
Gyre Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Gyre Therapeutics, Inc. expected to post a loss of 13 cents a share - Earnings Preview
Brief: Gyre Therapeutics Reports Second Quarter 2026
Gyre Therapeutics Q2 revenue beats estimates on higher ETUARY sales volumes